Development, Vol 126, Issue 9 1957-1965, Copyright © 1999 by Company of Biologists

JOURNAL ARTICLES

Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages

KL Kucharczuk, CM Love, NM Dougherty and DJ Goldhamer
Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, PA 19104, USA.

Skeletal muscle lineage determination is regulated by the myogenic regulatory genes, MyoD and Myf-5. Previously, we identified a 258 bp core enhancer element 20 kb 5' of the MyoD gene that regulates MyoD gene activation in mouse embryos. To elucidate the cis control mechanisms that regulate MyoD transcription, we have mutagenized the entire core enhancer using linker-scanner mutagenesis, and have tested the transcriptional activity of enhancer mutants using lacZ reporter gene expression in transgenic mouse embryos. In total, 83 stable transgenic lines representing 17 linker-scanner mutations were analyzed in midgestational mouse embryos. Eight linker-scanner mutations resulted in a partial or complete loss of enhancer activity, demonstrating that MyoD is primarily under positive transcriptional control. Six of these mutations reduced or abolished transgene expression in all skeletal muscle lineages, indicating that activation of MyoD expression in trunk, limb and head musculature is regulated, in part, by shared transcriptional mechanisms. Interestingly, however, two adjacent linker-scanner mutations (LS-14 and LS-15) resulted in a dramatic reduction in transgene expression specifically in myotomes at 11.5 days. At later stages, transgene expression was absent or greatly reduced in myotomally derived muscles including epaxial muscles (deep back muscles) and hypaxial muscles of the body wall (intercostal muscles, abdominal wall musculature). In contrast, head muscles, as well as muscles of the body derived from migrating muscle progenitor cells (e.g. limb, diaphragm), were unaffected by these mutations. In Pax-3-mutant mice, LS-14 and LS-15 transgene expression was eliminated in the body, but was unaffected in the head, yielding an identical expression pattern to the endogenous MyoD gene in mice mutant for both Myf-5 and Pax-3. These data support the hypothesis that LS-14 and LS-15 define the core enhancer targets for Myf-5-dependent activation of MyoD in myotomal muscles.

This article has been cited by other articles:

				H. Lee, J. C. Quinn, K. V. Prasanth, V. A. Swiss, K. D. Economides, M. M. Camacho, D. L. Spector, and C. Abate-Shen PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes & Dev., April 1, 2006; 20(7): 784 - 794. [Abstract] [Full Text] [PDF]

				H. W. Yang, J. L. Kutok, N. H. Lee, H. Y. Piao, C. D. M. Fletcher, J. P. Kanki, and A. T. Look Targeted Expression of Human MYCN Selectively Causes Pancreatic Neuroendocrine Tumors in Transgenic Zebrafish Cancer Res., October 15, 2004; 64(20): 7256 - 7262. [Abstract] [Full Text] [PDF]

				D. Kurokawa, N. Takasaki, H. Kiyonari, R. Nakayama, C. Kimura-Yoshida, I. Matsuo, and S. Aizawa Regulation of Otx2 expression and its functions in mouse epiblast and anterior neuroectoderm Development, July 15, 2004; 131(14): 3307 - 3317. [Abstract] [Full Text] [PDF]

				H. Lee, R. Habas, and C. Abate-Shen Msx1 Cooperates with Histone H1b for Inhibition of Transcription and Myogenesis Science, June 11, 2004; 304(5677): 1675 - 1678. [Abstract] [Full Text] [PDF]

				J. Hadchouel, J. J. Carvajal, P. Daubas, L. Bajard, T. Chang, D. Rocancourt, D. Cox, D. Summerbell, S. Tajbakhsh, P. W. J. Rigby, et al. Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus Development, August 1, 2003; 130(15): 3415 - 3426. [Abstract] [Full Text] [PDF]

				C. Laclef, G. Hamard, J. Demignon, E. Souil, C. Houbron, and P. Maire Altered myogenesis in Six1-deficient mice Development, May 15, 2003; 130(10): 2239 - 2252. [Abstract] [Full Text] [PDF]

				A. L'honore, N. J. Lamb, M. Vandromme, P. Turowski, G. Carnac, and A. Fernandez MyoD Distal Regulatory Region Contains an SRF Binding CArG Element Required for MyoD Expression in Skeletal Myoblasts and during Muscle Regeneration Mol. Biol. Cell, May 1, 2003; 14(5): 2151 - 2162. [Abstract] [Full Text] [PDF]

				J. J. Andreucci, D. Grant, D. M. Cox, L. K. Tomc, R. Prywes, D. J. Goldhamer, N. Rodrigues, P.-A. Bedard, and J. C. McDermott Composition and Function of AP-1 Transcription Complexes during Muscle Cell Differentiation J. Biol. Chem., May 3, 2002; 277(19): 16426 - 16432. [Abstract] [Full Text] [PDF]

				L. Teboul, J. Hadchouel, P. Daubas, D. Summerbell, M. Buckingham, and P. W. J. Rigby The early epaxial enhancer is essential for the initial expression of the skeletal muscle determination gene Myf5 but not for subsequent, multiple phases of somitic myogenesis Development, January 10, 2002; 129(19): 4571 - 4580. [Abstract] [Full Text] [PDF]

				J. Carvajal, D Cox, D Summerbell, and P. Rigby A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development Development, January 5, 2001; 128(10): 1857 - 1868. [Abstract] [PDF]

				F. Beranger, C. Mejean, B. Moniot, P. Berta, and M. Vandromme Muscle Differentiation Is Antagonized by SOX15, a New Member of the SOX Protein Family J. Biol. Chem., May 19, 2000; 275(21): 16103 - 16109. [Abstract] [Full Text] [PDF]

				J Hadchouel, S Tajbakhsh, M Primig, T. Chang, P Daubas, D Rocancourt, and M Buckingham Modular long-range regulation of Myf5 reveals unexpected heterogeneity between skeletal muscles in the mouse embryo Development, January 10, 2000; 127(20): 4455 - 4467. [Abstract] [PDF]

				D Summerbell, P. Ashby, O Coutelle, D Cox, S Yee, and P. Rigby The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of skeletal muscle precursors Development, January 9, 2000; 127(17): 3745 - 3757. [Abstract] [PDF]

				A. Bendall, J Ding, G Hu, M. Shen, and C Abate-Shen Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors Development, January 11, 1999; 126(22): 4965 - 4976. [Abstract] [PDF]